Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig
Clinical trial NCT03211065 · COMPLETED
Trial details
- NCT number
- NCT03211065
- Sponsor
- Rochester General Hospital
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-21
- Primary completion
- 2019-11-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.